I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 8 studies | 23% ± 6% | |
| epithelial cell | 6 studies | 30% ± 13% | |
| macrophage | 6 studies | 21% ± 4% | |
| natural killer cell | 5 studies | 20% ± 4% | |
| microglial cell | 5 studies | 20% ± 4% | |
| GABAergic neuron | 5 studies | 39% ± 19% | |
| oligodendrocyte | 5 studies | 25% ± 4% | |
| B cell | 4 studies | 18% ± 2% | |
| T cell | 4 studies | 16% ± 1% | |
| CD8-positive, alpha-beta T cell | 4 studies | 20% ± 3% | |
| basal cell | 4 studies | 23% ± 7% | |
| CD8-positive, alpha-beta memory T cell | 4 studies | 16% ± 1% | |
| astrocyte | 4 studies | 28% ± 6% | |
| glutamatergic neuron | 4 studies | 51% ± 19% | |
| oligodendrocyte precursor cell | 4 studies | 25% ± 8% | |
| fibroblast | 4 studies | 19% ± 6% | |
| endothelial cell of lymphatic vessel | 4 studies | 16% ± 2% | |
| interneuron | 4 studies | 36% ± 23% | |
| naive B cell | 3 studies | 17% ± 2% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 20% ± 2% | |
| CD4-positive, alpha-beta T cell | 3 studies | 21% ± 5% | |
| ciliated cell | 3 studies | 23% ± 4% | |
| lymphocyte | 3 studies | 23% ± 1% | |
| myeloid cell | 3 studies | 21% ± 3% | |
| monocyte | 3 studies | 19% ± 3% |
